PHARMACEUTICAL COMPOSITION CONTAINING ANTAGONIST LTB4 AND COX2 INHIBITOR OR COMBINED COX1 / COX2 INHIBITOR

摘要

The application describes a pharmaceutical composition comprising an LTB antagonist that carries a hydroxy and benzamidine group, or a tautomer thereof, a pharmaceutically acceptable salt or solvate, in particular a compound of formula (I), in which R and A have the meanings indicated in the claims, or its tautomer, pharmaceutically acceptable salt or solvate (1) and at least one cyclooxygenase-2 inhibitor, a combined cox1 / cox2 inhibitor or its pharmaceutically acceptable salt or solvate (), and a pharmaceutically acceptable carrier or excipient and not necessarily one or more other therapeutic ingredients. The international application was published along with an international search report.